Global Medical Weight Loss Drug Supply, Demand and Key Producers, 2026-2032
The global Medical Weight Loss Drug market size is expected to reach $ 62573 million by 2032, rising at a market growth of 13.4% CAGR during the forecast period (2026-2032).
In 2025, global Medical Weight Loss Drug production reached approximately 29 million doses, with an average global market price of around USD 850 per dose.
The gross profit margin of major companies in the industry is between 55%–75%.
In 2025, the global production capacity of Medical Weight Loss Drug was approximately 38 million doses.
Medical Weight Loss Drug refers to prescription pharmaceutical products designed for obesity treatment and weight management under medical supervision. These drugs help regulate appetite, metabolism, and energy balance through specific mechanisms. They are mainly used for obesity patients and overweight populations with related health risks, including injectable and oral therapies. The product scope covers approved pharmaceutical treatments for weight reduction and excludes supplements, health foods, and non-drug weight loss products.
The industry chain includes upstream pharmaceutical materials, midstream drug development and manufacturing, and downstream medical applications. Upstream provides active pharmaceutical ingredients and related materials. Midstream focuses on research, formulation, production, and quality control. Downstream includes hospitals, clinics, pharmacies, and patients who require medical weight management treatments.
This report is a detailed and comprehensive analysis of the world market for Medical Weight Loss Drug and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Medical Weight Loss Drug that contribute to its increasing demand across many markets.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Medical Weight Loss Drug market
2. What is the demand of the global Medical Weight Loss Drug market?
3. What is the year over year growth of the global Medical Weight Loss Drug market?
4. What is the production and production value of the global Medical Weight Loss Drug market?
5. Who are the key producers in the global Medical Weight Loss Drug market?
6. What are the growth factors driving the market demand?
In 2025, global Medical Weight Loss Drug production reached approximately 29 million doses, with an average global market price of around USD 850 per dose.
The gross profit margin of major companies in the industry is between 55%–75%.
In 2025, the global production capacity of Medical Weight Loss Drug was approximately 38 million doses.
Medical Weight Loss Drug refers to prescription pharmaceutical products designed for obesity treatment and weight management under medical supervision. These drugs help regulate appetite, metabolism, and energy balance through specific mechanisms. They are mainly used for obesity patients and overweight populations with related health risks, including injectable and oral therapies. The product scope covers approved pharmaceutical treatments for weight reduction and excludes supplements, health foods, and non-drug weight loss products.
The industry chain includes upstream pharmaceutical materials, midstream drug development and manufacturing, and downstream medical applications. Upstream provides active pharmaceutical ingredients and related materials. Midstream focuses on research, formulation, production, and quality control. Downstream includes hospitals, clinics, pharmacies, and patients who require medical weight management treatments.
Report Scope
This report studies the global Medical Weight Loss Drug production, demand, key manufacturers, and key regions.This report is a detailed and comprehensive analysis of the world market for Medical Weight Loss Drug and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Medical Weight Loss Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
- Global Medical Weight Loss Drug total production and demand, 2021-2032, (K Dose)
- Global Medical Weight Loss Drug total production value, 2021-2032, (USD Million)
- Global Medical Weight Loss Drug production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
- Global Medical Weight Loss Drug consumption by region & country, CAGR, 2021-2032 & (K Dose)
- U.S. VS China: Medical Weight Loss Drug domestic production, consumption, key domestic manufacturers and share
- Global Medical Weight Loss Drug production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
- Global Medical Weight Loss Drug production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
- Global Medical Weight Loss Drug production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Medical Weight Loss Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.Global Medical Weight Loss Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
Market Segmentation
Global Medical Weight Loss Drug Market, Segmentation by Type:
- GLP-1 Receptor Agonist Drugs
- Dual GIP/GLP-1 Receptor Agonist Drugs
- Other Metabolic Pathway Drugs
Global Medical Weight Loss Drug Market, Segmentation by Administration Route:
- Injectable Weight Loss Drugs
- Oral Weight Loss Drugs
- Implantable Weight Loss Drugs
Global Medical Weight Loss Drug Market, Segmentation by Dosage Form Strength:
- Low Dose Formulation (<5 mg per dose)
- Medium Dose Formulation (5–10 mg per dose)
- High Dose Formulation (>10 mg per dose)
Global Medical Weight Loss Drug Market, Segmentation by Application:
- Obesity Treatment
- Overweight Management
- Weight-Related Metabolic Disease Treatment
- Other
Companies Profiled:
- Novo Nordisk A/S
- Eli Lilly and Company
- Amgen Inc.
- Altimmune, Inc.
- Viking Therapeutics, Inc.
- Structure Therapeutics Inc.
- Boehringer Ingelheim International GmbH
- Rhythm Pharmaceuticals, Inc.
- Pfizer Inc.
- Innovent Biologics, Inc.
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Shanghai Junshi Biosciences Co., Ltd.
- Hangzhou Jiuyuan Gene Engineering Co., Ltd.
- Haisco Pharmaceutical Group Co., Ltd.
- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
- Tonghua Dongbao Pharmaceutical Co., Ltd.
- Gan & Lee Pharmaceuticals Co., Ltd.
- Huadong Medicine Co., Ltd.
- Livzon Pharmaceutical Group Inc.
- CSPC Pharmaceutical Group Limited
Key Questions Answered:
1. How big is the global Medical Weight Loss Drug market?2. What is the demand of the global Medical Weight Loss Drug market?
3. What is the year over year growth of the global Medical Weight Loss Drug market?
4. What is the production and production value of the global Medical Weight Loss Drug market?
5. Who are the key producers in the global Medical Weight Loss Drug market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Medical Weight Loss Drug Introduction
1.2 World Medical Weight Loss Drug Supply & Forecast
1.2.1 World Medical Weight Loss Drug Production Value (2021 & 2025 & 2032)
1.2.2 World Medical Weight Loss Drug Production (2021-2032)
1.2.3 World Medical Weight Loss Drug Pricing Trends (2021-2032)
1.3 World Medical Weight Loss Drug Production by Region (Based on Production Site)
1.3.1 World Medical Weight Loss Drug Production Value by Region (2021-2032)
1.3.2 World Medical Weight Loss Drug Production by Region (2021-2032)
1.3.3 World Medical Weight Loss Drug Average Price by Region (2021-2032)
1.3.4 North America Medical Weight Loss Drug Production (2021-2032)
1.3.5 Europe Medical Weight Loss Drug Production (2021-2032)
1.3.6 China Medical Weight Loss Drug Production (2021-2032)
1.3.7 Japan Medical Weight Loss Drug Production (2021-2032)
1.3.8 India Medical Weight Loss Drug Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Medical Weight Loss Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Medical Weight Loss Drug Major Market Trends
2 DEMAND SUMMARY
2.1 World Medical Weight Loss Drug Demand (2021-2032)
2.2 World Medical Weight Loss Drug Consumption by Region
2.2.1 World Medical Weight Loss Drug Consumption by Region (2021-2026)
2.2.2 World Medical Weight Loss Drug Consumption Forecast by Region (2027-2032)
2.3 United States Medical Weight Loss Drug Consumption (2021-2032)
2.4 China Medical Weight Loss Drug Consumption (2021-2032)
2.5 Europe Medical Weight Loss Drug Consumption (2021-2032)
2.6 Japan Medical Weight Loss Drug Consumption (2021-2032)
2.7 South Korea Medical Weight Loss Drug Consumption (2021-2032)
2.8 ASEAN Medical Weight Loss Drug Consumption (2021-2032)
2.9 India Medical Weight Loss Drug Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Medical Weight Loss Drug Production Value by Manufacturer (2021-2026)
3.2 World Medical Weight Loss Drug Production by Manufacturer (2021-2026)
3.3 World Medical Weight Loss Drug Average Price by Manufacturer (2021-2026)
3.4 Medical Weight Loss Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Medical Weight Loss Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Medical Weight Loss Drug in 2025
3.5.3 Global Concentration Ratios (CR8) for Medical Weight Loss Drug in 2025
3.6 Medical Weight Loss Drug Market: Overall Company Footprint Analysis
3.6.1 Medical Weight Loss Drug Market: Region Footprint
3.6.2 Medical Weight Loss Drug Market: Company Product Type Footprint
3.6.3 Medical Weight Loss Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Medical Weight Loss Drug Production Value Comparison
4.1.1 United States VS China: Medical Weight Loss Drug Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Medical Weight Loss Drug Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Medical Weight Loss Drug Production Comparison
4.2.1 United States VS China: Medical Weight Loss Drug Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Medical Weight Loss Drug Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Medical Weight Loss Drug Consumption Comparison
4.3.1 United States VS China: Medical Weight Loss Drug Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Medical Weight Loss Drug Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Medical Weight Loss Drug Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Medical Weight Loss Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Medical Weight Loss Drug Production Value (2021-2026)
4.4.3 United States Based Manufacturers Medical Weight Loss Drug Production (2021-2026)
4.5 China Based Medical Weight Loss Drug Manufacturers and Market Share
4.5.1 China Based Medical Weight Loss Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Medical Weight Loss Drug Production Value (2021-2026)
4.5.3 China Based Manufacturers Medical Weight Loss Drug Production (2021-2026)
4.6 Rest of World Based Medical Weight Loss Drug Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Medical Weight Loss Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Medical Weight Loss Drug Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Medical Weight Loss Drug Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Medical Weight Loss Drug Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 GLP-1 Receptor Agonist Drugs
5.2.2 Dual GIP/GLP-1 Receptor Agonist Drugs
5.2.3 Other Metabolic Pathway Drugs
5.3 Market Segment by Type
5.3.1 World Medical Weight Loss Drug Production by Type (2021-2032)
5.3.2 World Medical Weight Loss Drug Production Value by Type (2021-2032)
5.3.3 World Medical Weight Loss Drug Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY ADMINISTRATION ROUTE
6.1 World Medical Weight Loss Drug Market Size Overview by Administration Route: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Administration Route
6.2.1 Injectable Weight Loss Drugs
6.2.2 Oral Weight Loss Drugs
6.2.3 Implantable Weight Loss Drugs
6.3 Market Segment by Administration Route
6.3.1 World Medical Weight Loss Drug Production by Administration Route (2021-2032)
6.3.2 World Medical Weight Loss Drug Production Value by Administration Route (2021-2032)
6.3.3 World Medical Weight Loss Drug Average Price by Administration Route (2021-2032)
7 MARKET ANALYSIS BY DOSAGE FORM STRENGTH
7.1 World Medical Weight Loss Drug Market Size Overview by Dosage Form Strength: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Dosage Form Strength
7.2.1 Low Dose Formulation (<5 mg per dose)
7.2.2 Medium Dose Formulation (5–10 mg per dose)
7.2.3 High Dose Formulation (>10 mg per dose)
7.3 Market Segment by Dosage Form Strength
7.3.1 World Medical Weight Loss Drug Production by Dosage Form Strength (2021-2032)
7.3.2 World Medical Weight Loss Drug Production Value by Dosage Form Strength (2021-2032)
7.3.3 World Medical Weight Loss Drug Average Price by Dosage Form Strength (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Medical Weight Loss Drug Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Obesity Treatment
8.2.2 Overweight Management
8.2.3 Weight-Related Metabolic Disease Treatment
8.2.4 Other
8.3 Market Segment by Application
8.3.1 World Medical Weight Loss Drug Production by Application (2021-2032)
8.3.2 World Medical Weight Loss Drug Production Value by Application (2021-2032)
8.3.3 World Medical Weight Loss Drug Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Novo Nordisk A/S
9.1.1 Novo Nordisk A/S Details
9.1.2 Novo Nordisk A/S Major Business
9.1.3 Novo Nordisk A/S Medical Weight Loss Drug Product and Services
9.1.4 Novo Nordisk A/S Medical Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Novo Nordisk A/S Recent Developments/Updates
9.1.6 Novo Nordisk A/S Competitive Strengths & Weaknesses
9.2 Eli Lilly and Company
9.2.1 Eli Lilly and Company Details
9.2.2 Eli Lilly and Company Major Business
9.2.3 Eli Lilly and Company Medical Weight Loss Drug Product and Services
9.2.4 Eli Lilly and Company Medical Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Eli Lilly and Company Recent Developments/Updates
9.2.6 Eli Lilly and Company Competitive Strengths & Weaknesses
9.3 Amgen Inc.
9.3.1 Amgen Inc. Details
9.3.2 Amgen Inc. Major Business
9.3.3 Amgen Inc. Medical Weight Loss Drug Product and Services
9.3.4 Amgen Inc. Medical Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Amgen Inc. Recent Developments/Updates
9.3.6 Amgen Inc. Competitive Strengths & Weaknesses
9.4 Altimmune, Inc.
9.4.1 Altimmune, Inc. Details
9.4.2 Altimmune, Inc. Major Business
9.4.3 Altimmune, Inc. Medical Weight Loss Drug Product and Services
9.4.4 Altimmune, Inc. Medical Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Altimmune, Inc. Recent Developments/Updates
9.4.6 Altimmune, Inc. Competitive Strengths & Weaknesses
9.5 Viking Therapeutics, Inc.
9.5.1 Viking Therapeutics, Inc. Details
9.5.2 Viking Therapeutics, Inc. Major Business
9.5.3 Viking Therapeutics, Inc. Medical Weight Loss Drug Product and Services
9.5.4 Viking Therapeutics, Inc. Medical Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Viking Therapeutics, Inc. Recent Developments/Updates
9.5.6 Viking Therapeutics, Inc. Competitive Strengths & Weaknesses
9.6 Structure Therapeutics Inc.
9.6.1 Structure Therapeutics Inc. Details
9.6.2 Structure Therapeutics Inc. Major Business
9.6.3 Structure Therapeutics Inc. Medical Weight Loss Drug Product and Services
9.6.4 Structure Therapeutics Inc. Medical Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Structure Therapeutics Inc. Recent Developments/Updates
9.6.6 Structure Therapeutics Inc. Competitive Strengths & Weaknesses
9.7 Boehringer Ingelheim International GmbH
9.7.1 Boehringer Ingelheim International GmbH Details
9.7.2 Boehringer Ingelheim International GmbH Major Business
9.7.3 Boehringer Ingelheim International GmbH Medical Weight Loss Drug Product and Services
9.7.4 Boehringer Ingelheim International GmbH Medical Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Boehringer Ingelheim International GmbH Recent Developments/Updates
9.7.6 Boehringer Ingelheim International GmbH Competitive Strengths & Weaknesses
9.8 Rhythm Pharmaceuticals, Inc.
9.8.1 Rhythm Pharmaceuticals, Inc. Details
9.8.2 Rhythm Pharmaceuticals, Inc. Major Business
9.8.3 Rhythm Pharmaceuticals, Inc. Medical Weight Loss Drug Product and Services
9.8.4 Rhythm Pharmaceuticals, Inc. Medical Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Rhythm Pharmaceuticals, Inc. Recent Developments/Updates
9.8.6 Rhythm Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
9.9 Pfizer Inc.
9.9.1 Pfizer Inc. Details
9.9.2 Pfizer Inc. Major Business
9.9.3 Pfizer Inc. Medical Weight Loss Drug Product and Services
9.9.4 Pfizer Inc. Medical Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Pfizer Inc. Recent Developments/Updates
9.9.6 Pfizer Inc. Competitive Strengths & Weaknesses
9.10 Innovent Biologics, Inc.
9.10.1 Innovent Biologics, Inc. Details
9.10.2 Innovent Biologics, Inc. Major Business
9.10.3 Innovent Biologics, Inc. Medical Weight Loss Drug Product and Services
9.10.4 Innovent Biologics, Inc. Medical Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Innovent Biologics, Inc. Recent Developments/Updates
9.10.6 Innovent Biologics, Inc. Competitive Strengths & Weaknesses
9.11 Jiangsu Hengrui Pharmaceuticals Co., Ltd.
9.11.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Details
9.11.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Major Business
9.11.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Medical Weight Loss Drug Product and Services
9.11.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Medical Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Developments/Updates
9.11.6 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Competitive Strengths & Weaknesses
9.12 Shanghai Junshi Biosciences Co., Ltd.
9.12.1 Shanghai Junshi Biosciences Co., Ltd. Details
9.12.2 Shanghai Junshi Biosciences Co., Ltd. Major Business
9.12.3 Shanghai Junshi Biosciences Co., Ltd. Medical Weight Loss Drug Product and Services
9.12.4 Shanghai Junshi Biosciences Co., Ltd. Medical Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Shanghai Junshi Biosciences Co., Ltd. Recent Developments/Updates
9.12.6 Shanghai Junshi Biosciences Co., Ltd. Competitive Strengths & Weaknesses
9.13 Hangzhou Jiuyuan Gene Engineering Co., Ltd.
9.13.1 Hangzhou Jiuyuan Gene Engineering Co., Ltd. Details
9.13.2 Hangzhou Jiuyuan Gene Engineering Co., Ltd. Major Business
9.13.3 Hangzhou Jiuyuan Gene Engineering Co., Ltd. Medical Weight Loss Drug Product and Services
9.13.4 Hangzhou Jiuyuan Gene Engineering Co., Ltd. Medical Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Hangzhou Jiuyuan Gene Engineering Co., Ltd. Recent Developments/Updates
9.13.6 Hangzhou Jiuyuan Gene Engineering Co., Ltd. Competitive Strengths & Weaknesses
9.14 Haisco Pharmaceutical Group Co., Ltd.
9.14.1 Haisco Pharmaceutical Group Co., Ltd. Details
9.14.2 Haisco Pharmaceutical Group Co., Ltd. Major Business
9.14.3 Haisco Pharmaceutical Group Co., Ltd. Medical Weight Loss Drug Product and Services
9.14.4 Haisco Pharmaceutical Group Co., Ltd. Medical Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Haisco Pharmaceutical Group Co., Ltd. Recent Developments/Updates
9.14.6 Haisco Pharmaceutical Group Co., Ltd. Competitive Strengths & Weaknesses
9.15 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
9.15.1 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Details
9.15.2 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Major Business
9.15.3 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Medical Weight Loss Drug Product and Services
9.15.4 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Medical Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Recent Developments/Updates
9.15.6 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
9.16 Tonghua Dongbao Pharmaceutical Co., Ltd.
9.16.1 Tonghua Dongbao Pharmaceutical Co., Ltd. Details
9.16.2 Tonghua Dongbao Pharmaceutical Co., Ltd. Major Business
9.16.3 Tonghua Dongbao Pharmaceutical Co., Ltd. Medical Weight Loss Drug Product and Services
9.16.4 Tonghua Dongbao Pharmaceutical Co., Ltd. Medical Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Tonghua Dongbao Pharmaceutical Co., Ltd. Recent Developments/Updates
9.16.6 Tonghua Dongbao Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
9.17 Gan & Lee Pharmaceuticals Co., Ltd.
9.17.1 Gan & Lee Pharmaceuticals Co., Ltd. Details
9.17.2 Gan & Lee Pharmaceuticals Co., Ltd. Major Business
9.17.3 Gan & Lee Pharmaceuticals Co., Ltd. Medical Weight Loss Drug Product and Services
9.17.4 Gan & Lee Pharmaceuticals Co., Ltd. Medical Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 Gan & Lee Pharmaceuticals Co., Ltd. Recent Developments/Updates
9.17.6 Gan & Lee Pharmaceuticals Co., Ltd. Competitive Strengths & Weaknesses
9.18 Huadong Medicine Co., Ltd.
9.18.1 Huadong Medicine Co., Ltd. Details
9.18.2 Huadong Medicine Co., Ltd. Major Business
9.18.3 Huadong Medicine Co., Ltd. Medical Weight Loss Drug Product and Services
9.18.4 Huadong Medicine Co., Ltd. Medical Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.18.5 Huadong Medicine Co., Ltd. Recent Developments/Updates
9.18.6 Huadong Medicine Co., Ltd. Competitive Strengths & Weaknesses
9.19 Livzon Pharmaceutical Group Inc.
9.19.1 Livzon Pharmaceutical Group Inc. Details
9.19.2 Livzon Pharmaceutical Group Inc. Major Business
9.19.3 Livzon Pharmaceutical Group Inc. Medical Weight Loss Drug Product and Services
9.19.4 Livzon Pharmaceutical Group Inc. Medical Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.19.5 Livzon Pharmaceutical Group Inc. Recent Developments/Updates
9.19.6 Livzon Pharmaceutical Group Inc. Competitive Strengths & Weaknesses
9.20 CSPC Pharmaceutical Group Limited
9.20.1 CSPC Pharmaceutical Group Limited Details
9.20.2 CSPC Pharmaceutical Group Limited Major Business
9.20.3 CSPC Pharmaceutical Group Limited Medical Weight Loss Drug Product and Services
9.20.4 CSPC Pharmaceutical Group Limited Medical Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.20.5 CSPC Pharmaceutical Group Limited Recent Developments/Updates
9.20.6 CSPC Pharmaceutical Group Limited Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Medical Weight Loss Drug Industry Chain
10.2 Medical Weight Loss Drug Upstream Analysis
10.2.1 Medical Weight Loss Drug Core Raw Materials
10.2.2 Main Manufacturers of Medical Weight Loss Drug Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Medical Weight Loss Drug Production Mode
10.6 Medical Weight Loss Drug Procurement Model
10.7 Medical Weight Loss Drug Industry Sales Model and Sales Channels
10.7.1 Medical Weight Loss Drug Sales Model
10.7.2 Medical Weight Loss Drug Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Medical Weight Loss Drug Introduction
1.2 World Medical Weight Loss Drug Supply & Forecast
1.2.1 World Medical Weight Loss Drug Production Value (2021 & 2025 & 2032)
1.2.2 World Medical Weight Loss Drug Production (2021-2032)
1.2.3 World Medical Weight Loss Drug Pricing Trends (2021-2032)
1.3 World Medical Weight Loss Drug Production by Region (Based on Production Site)
1.3.1 World Medical Weight Loss Drug Production Value by Region (2021-2032)
1.3.2 World Medical Weight Loss Drug Production by Region (2021-2032)
1.3.3 World Medical Weight Loss Drug Average Price by Region (2021-2032)
1.3.4 North America Medical Weight Loss Drug Production (2021-2032)
1.3.5 Europe Medical Weight Loss Drug Production (2021-2032)
1.3.6 China Medical Weight Loss Drug Production (2021-2032)
1.3.7 Japan Medical Weight Loss Drug Production (2021-2032)
1.3.8 India Medical Weight Loss Drug Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Medical Weight Loss Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Medical Weight Loss Drug Major Market Trends
2 DEMAND SUMMARY
2.1 World Medical Weight Loss Drug Demand (2021-2032)
2.2 World Medical Weight Loss Drug Consumption by Region
2.2.1 World Medical Weight Loss Drug Consumption by Region (2021-2026)
2.2.2 World Medical Weight Loss Drug Consumption Forecast by Region (2027-2032)
2.3 United States Medical Weight Loss Drug Consumption (2021-2032)
2.4 China Medical Weight Loss Drug Consumption (2021-2032)
2.5 Europe Medical Weight Loss Drug Consumption (2021-2032)
2.6 Japan Medical Weight Loss Drug Consumption (2021-2032)
2.7 South Korea Medical Weight Loss Drug Consumption (2021-2032)
2.8 ASEAN Medical Weight Loss Drug Consumption (2021-2032)
2.9 India Medical Weight Loss Drug Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Medical Weight Loss Drug Production Value by Manufacturer (2021-2026)
3.2 World Medical Weight Loss Drug Production by Manufacturer (2021-2026)
3.3 World Medical Weight Loss Drug Average Price by Manufacturer (2021-2026)
3.4 Medical Weight Loss Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Medical Weight Loss Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Medical Weight Loss Drug in 2025
3.5.3 Global Concentration Ratios (CR8) for Medical Weight Loss Drug in 2025
3.6 Medical Weight Loss Drug Market: Overall Company Footprint Analysis
3.6.1 Medical Weight Loss Drug Market: Region Footprint
3.6.2 Medical Weight Loss Drug Market: Company Product Type Footprint
3.6.3 Medical Weight Loss Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Medical Weight Loss Drug Production Value Comparison
4.1.1 United States VS China: Medical Weight Loss Drug Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Medical Weight Loss Drug Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Medical Weight Loss Drug Production Comparison
4.2.1 United States VS China: Medical Weight Loss Drug Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Medical Weight Loss Drug Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Medical Weight Loss Drug Consumption Comparison
4.3.1 United States VS China: Medical Weight Loss Drug Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Medical Weight Loss Drug Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Medical Weight Loss Drug Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Medical Weight Loss Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Medical Weight Loss Drug Production Value (2021-2026)
4.4.3 United States Based Manufacturers Medical Weight Loss Drug Production (2021-2026)
4.5 China Based Medical Weight Loss Drug Manufacturers and Market Share
4.5.1 China Based Medical Weight Loss Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Medical Weight Loss Drug Production Value (2021-2026)
4.5.3 China Based Manufacturers Medical Weight Loss Drug Production (2021-2026)
4.6 Rest of World Based Medical Weight Loss Drug Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Medical Weight Loss Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Medical Weight Loss Drug Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Medical Weight Loss Drug Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Medical Weight Loss Drug Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 GLP-1 Receptor Agonist Drugs
5.2.2 Dual GIP/GLP-1 Receptor Agonist Drugs
5.2.3 Other Metabolic Pathway Drugs
5.3 Market Segment by Type
5.3.1 World Medical Weight Loss Drug Production by Type (2021-2032)
5.3.2 World Medical Weight Loss Drug Production Value by Type (2021-2032)
5.3.3 World Medical Weight Loss Drug Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY ADMINISTRATION ROUTE
6.1 World Medical Weight Loss Drug Market Size Overview by Administration Route: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Administration Route
6.2.1 Injectable Weight Loss Drugs
6.2.2 Oral Weight Loss Drugs
6.2.3 Implantable Weight Loss Drugs
6.3 Market Segment by Administration Route
6.3.1 World Medical Weight Loss Drug Production by Administration Route (2021-2032)
6.3.2 World Medical Weight Loss Drug Production Value by Administration Route (2021-2032)
6.3.3 World Medical Weight Loss Drug Average Price by Administration Route (2021-2032)
7 MARKET ANALYSIS BY DOSAGE FORM STRENGTH
7.1 World Medical Weight Loss Drug Market Size Overview by Dosage Form Strength: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Dosage Form Strength
7.2.1 Low Dose Formulation (<5 mg per dose)
7.2.2 Medium Dose Formulation (5–10 mg per dose)
7.2.3 High Dose Formulation (>10 mg per dose)
7.3 Market Segment by Dosage Form Strength
7.3.1 World Medical Weight Loss Drug Production by Dosage Form Strength (2021-2032)
7.3.2 World Medical Weight Loss Drug Production Value by Dosage Form Strength (2021-2032)
7.3.3 World Medical Weight Loss Drug Average Price by Dosage Form Strength (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Medical Weight Loss Drug Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Obesity Treatment
8.2.2 Overweight Management
8.2.3 Weight-Related Metabolic Disease Treatment
8.2.4 Other
8.3 Market Segment by Application
8.3.1 World Medical Weight Loss Drug Production by Application (2021-2032)
8.3.2 World Medical Weight Loss Drug Production Value by Application (2021-2032)
8.3.3 World Medical Weight Loss Drug Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Novo Nordisk A/S
9.1.1 Novo Nordisk A/S Details
9.1.2 Novo Nordisk A/S Major Business
9.1.3 Novo Nordisk A/S Medical Weight Loss Drug Product and Services
9.1.4 Novo Nordisk A/S Medical Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Novo Nordisk A/S Recent Developments/Updates
9.1.6 Novo Nordisk A/S Competitive Strengths & Weaknesses
9.2 Eli Lilly and Company
9.2.1 Eli Lilly and Company Details
9.2.2 Eli Lilly and Company Major Business
9.2.3 Eli Lilly and Company Medical Weight Loss Drug Product and Services
9.2.4 Eli Lilly and Company Medical Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Eli Lilly and Company Recent Developments/Updates
9.2.6 Eli Lilly and Company Competitive Strengths & Weaknesses
9.3 Amgen Inc.
9.3.1 Amgen Inc. Details
9.3.2 Amgen Inc. Major Business
9.3.3 Amgen Inc. Medical Weight Loss Drug Product and Services
9.3.4 Amgen Inc. Medical Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Amgen Inc. Recent Developments/Updates
9.3.6 Amgen Inc. Competitive Strengths & Weaknesses
9.4 Altimmune, Inc.
9.4.1 Altimmune, Inc. Details
9.4.2 Altimmune, Inc. Major Business
9.4.3 Altimmune, Inc. Medical Weight Loss Drug Product and Services
9.4.4 Altimmune, Inc. Medical Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Altimmune, Inc. Recent Developments/Updates
9.4.6 Altimmune, Inc. Competitive Strengths & Weaknesses
9.5 Viking Therapeutics, Inc.
9.5.1 Viking Therapeutics, Inc. Details
9.5.2 Viking Therapeutics, Inc. Major Business
9.5.3 Viking Therapeutics, Inc. Medical Weight Loss Drug Product and Services
9.5.4 Viking Therapeutics, Inc. Medical Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Viking Therapeutics, Inc. Recent Developments/Updates
9.5.6 Viking Therapeutics, Inc. Competitive Strengths & Weaknesses
9.6 Structure Therapeutics Inc.
9.6.1 Structure Therapeutics Inc. Details
9.6.2 Structure Therapeutics Inc. Major Business
9.6.3 Structure Therapeutics Inc. Medical Weight Loss Drug Product and Services
9.6.4 Structure Therapeutics Inc. Medical Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Structure Therapeutics Inc. Recent Developments/Updates
9.6.6 Structure Therapeutics Inc. Competitive Strengths & Weaknesses
9.7 Boehringer Ingelheim International GmbH
9.7.1 Boehringer Ingelheim International GmbH Details
9.7.2 Boehringer Ingelheim International GmbH Major Business
9.7.3 Boehringer Ingelheim International GmbH Medical Weight Loss Drug Product and Services
9.7.4 Boehringer Ingelheim International GmbH Medical Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Boehringer Ingelheim International GmbH Recent Developments/Updates
9.7.6 Boehringer Ingelheim International GmbH Competitive Strengths & Weaknesses
9.8 Rhythm Pharmaceuticals, Inc.
9.8.1 Rhythm Pharmaceuticals, Inc. Details
9.8.2 Rhythm Pharmaceuticals, Inc. Major Business
9.8.3 Rhythm Pharmaceuticals, Inc. Medical Weight Loss Drug Product and Services
9.8.4 Rhythm Pharmaceuticals, Inc. Medical Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Rhythm Pharmaceuticals, Inc. Recent Developments/Updates
9.8.6 Rhythm Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
9.9 Pfizer Inc.
9.9.1 Pfizer Inc. Details
9.9.2 Pfizer Inc. Major Business
9.9.3 Pfizer Inc. Medical Weight Loss Drug Product and Services
9.9.4 Pfizer Inc. Medical Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Pfizer Inc. Recent Developments/Updates
9.9.6 Pfizer Inc. Competitive Strengths & Weaknesses
9.10 Innovent Biologics, Inc.
9.10.1 Innovent Biologics, Inc. Details
9.10.2 Innovent Biologics, Inc. Major Business
9.10.3 Innovent Biologics, Inc. Medical Weight Loss Drug Product and Services
9.10.4 Innovent Biologics, Inc. Medical Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Innovent Biologics, Inc. Recent Developments/Updates
9.10.6 Innovent Biologics, Inc. Competitive Strengths & Weaknesses
9.11 Jiangsu Hengrui Pharmaceuticals Co., Ltd.
9.11.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Details
9.11.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Major Business
9.11.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Medical Weight Loss Drug Product and Services
9.11.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Medical Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Developments/Updates
9.11.6 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Competitive Strengths & Weaknesses
9.12 Shanghai Junshi Biosciences Co., Ltd.
9.12.1 Shanghai Junshi Biosciences Co., Ltd. Details
9.12.2 Shanghai Junshi Biosciences Co., Ltd. Major Business
9.12.3 Shanghai Junshi Biosciences Co., Ltd. Medical Weight Loss Drug Product and Services
9.12.4 Shanghai Junshi Biosciences Co., Ltd. Medical Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Shanghai Junshi Biosciences Co., Ltd. Recent Developments/Updates
9.12.6 Shanghai Junshi Biosciences Co., Ltd. Competitive Strengths & Weaknesses
9.13 Hangzhou Jiuyuan Gene Engineering Co., Ltd.
9.13.1 Hangzhou Jiuyuan Gene Engineering Co., Ltd. Details
9.13.2 Hangzhou Jiuyuan Gene Engineering Co., Ltd. Major Business
9.13.3 Hangzhou Jiuyuan Gene Engineering Co., Ltd. Medical Weight Loss Drug Product and Services
9.13.4 Hangzhou Jiuyuan Gene Engineering Co., Ltd. Medical Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Hangzhou Jiuyuan Gene Engineering Co., Ltd. Recent Developments/Updates
9.13.6 Hangzhou Jiuyuan Gene Engineering Co., Ltd. Competitive Strengths & Weaknesses
9.14 Haisco Pharmaceutical Group Co., Ltd.
9.14.1 Haisco Pharmaceutical Group Co., Ltd. Details
9.14.2 Haisco Pharmaceutical Group Co., Ltd. Major Business
9.14.3 Haisco Pharmaceutical Group Co., Ltd. Medical Weight Loss Drug Product and Services
9.14.4 Haisco Pharmaceutical Group Co., Ltd. Medical Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Haisco Pharmaceutical Group Co., Ltd. Recent Developments/Updates
9.14.6 Haisco Pharmaceutical Group Co., Ltd. Competitive Strengths & Weaknesses
9.15 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
9.15.1 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Details
9.15.2 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Major Business
9.15.3 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Medical Weight Loss Drug Product and Services
9.15.4 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Medical Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Recent Developments/Updates
9.15.6 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
9.16 Tonghua Dongbao Pharmaceutical Co., Ltd.
9.16.1 Tonghua Dongbao Pharmaceutical Co., Ltd. Details
9.16.2 Tonghua Dongbao Pharmaceutical Co., Ltd. Major Business
9.16.3 Tonghua Dongbao Pharmaceutical Co., Ltd. Medical Weight Loss Drug Product and Services
9.16.4 Tonghua Dongbao Pharmaceutical Co., Ltd. Medical Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Tonghua Dongbao Pharmaceutical Co., Ltd. Recent Developments/Updates
9.16.6 Tonghua Dongbao Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
9.17 Gan & Lee Pharmaceuticals Co., Ltd.
9.17.1 Gan & Lee Pharmaceuticals Co., Ltd. Details
9.17.2 Gan & Lee Pharmaceuticals Co., Ltd. Major Business
9.17.3 Gan & Lee Pharmaceuticals Co., Ltd. Medical Weight Loss Drug Product and Services
9.17.4 Gan & Lee Pharmaceuticals Co., Ltd. Medical Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 Gan & Lee Pharmaceuticals Co., Ltd. Recent Developments/Updates
9.17.6 Gan & Lee Pharmaceuticals Co., Ltd. Competitive Strengths & Weaknesses
9.18 Huadong Medicine Co., Ltd.
9.18.1 Huadong Medicine Co., Ltd. Details
9.18.2 Huadong Medicine Co., Ltd. Major Business
9.18.3 Huadong Medicine Co., Ltd. Medical Weight Loss Drug Product and Services
9.18.4 Huadong Medicine Co., Ltd. Medical Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.18.5 Huadong Medicine Co., Ltd. Recent Developments/Updates
9.18.6 Huadong Medicine Co., Ltd. Competitive Strengths & Weaknesses
9.19 Livzon Pharmaceutical Group Inc.
9.19.1 Livzon Pharmaceutical Group Inc. Details
9.19.2 Livzon Pharmaceutical Group Inc. Major Business
9.19.3 Livzon Pharmaceutical Group Inc. Medical Weight Loss Drug Product and Services
9.19.4 Livzon Pharmaceutical Group Inc. Medical Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.19.5 Livzon Pharmaceutical Group Inc. Recent Developments/Updates
9.19.6 Livzon Pharmaceutical Group Inc. Competitive Strengths & Weaknesses
9.20 CSPC Pharmaceutical Group Limited
9.20.1 CSPC Pharmaceutical Group Limited Details
9.20.2 CSPC Pharmaceutical Group Limited Major Business
9.20.3 CSPC Pharmaceutical Group Limited Medical Weight Loss Drug Product and Services
9.20.4 CSPC Pharmaceutical Group Limited Medical Weight Loss Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.20.5 CSPC Pharmaceutical Group Limited Recent Developments/Updates
9.20.6 CSPC Pharmaceutical Group Limited Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Medical Weight Loss Drug Industry Chain
10.2 Medical Weight Loss Drug Upstream Analysis
10.2.1 Medical Weight Loss Drug Core Raw Materials
10.2.2 Main Manufacturers of Medical Weight Loss Drug Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Medical Weight Loss Drug Production Mode
10.6 Medical Weight Loss Drug Procurement Model
10.7 Medical Weight Loss Drug Industry Sales Model and Sales Channels
10.7.1 Medical Weight Loss Drug Sales Model
10.7.2 Medical Weight Loss Drug Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Medical Weight Loss Drug Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Medical Weight Loss Drug Production Value by Region (2021-2026) & (USD Million)
Table 3. World Medical Weight Loss Drug Production Value by Region (2027-2032) & (USD Million)
Table 4. World Medical Weight Loss Drug Production Value Market Share by Region (2021-2026)
Table 5. World Medical Weight Loss Drug Production Value Market Share by Region (2027-2032)
Table 6. World Medical Weight Loss Drug Production by Region (2021-2026) & (K Dose)
Table 7. World Medical Weight Loss Drug Production by Region (2027-2032) & (K Dose)
Table 8. World Medical Weight Loss Drug Production Market Share by Region (2021-2026)
Table 9. World Medical Weight Loss Drug Production Market Share by Region (2027-2032)
Table 10. World Medical Weight Loss Drug Average Price by Region (2021-2026) & (US$/Dose)
Table 11. World Medical Weight Loss Drug Average Price by Region (2027-2032) & (US$/Dose)
Table 12. Medical Weight Loss Drug Major Market Trends
Table 13. World Medical Weight Loss Drug Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World Medical Weight Loss Drug Consumption by Region (2021-2026) & (K Dose)
Table 15. World Medical Weight Loss Drug Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World Medical Weight Loss Drug Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Medical Weight Loss Drug Producers in 2025
Table 18. World Medical Weight Loss Drug Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key Medical Weight Loss Drug Producers in 2025
Table 20. World Medical Weight Loss Drug Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 21. Global Medical Weight Loss Drug Company Evaluation Quadrant
Table 22. World Medical Weight Loss Drug Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Medical Weight Loss Drug Production Site of Key Manufacturer
Table 24. Medical Weight Loss Drug Market: Company Product Type Footprint
Table 25. Medical Weight Loss Drug Market: Company Product Application Footprint
Table 26. Medical Weight Loss Drug Competitive Factors
Table 27. Medical Weight Loss Drug New Entrant and Capacity Expansion Plans
Table 28. Medical Weight Loss Drug Mergers & Acquisitions Activity
Table 29. United States VS China Medical Weight Loss Drug Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Medical Weight Loss Drug Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China Medical Weight Loss Drug Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based Medical Weight Loss Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Medical Weight Loss Drug Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Medical Weight Loss Drug Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Medical Weight Loss Drug Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers Medical Weight Loss Drug Production Market Share (2021-2026)
Table 37. China Based Medical Weight Loss Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Medical Weight Loss Drug Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Medical Weight Loss Drug Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Medical Weight Loss Drug Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers Medical Weight Loss Drug Production Market Share (2021-2026)
Table 42. Rest of World Based Medical Weight Loss Drug Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Medical Weight Loss Drug Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Medical Weight Loss Drug Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Medical Weight Loss Drug Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers Medical Weight Loss Drug Production Market Share (2021-2026)
Table 47. World Medical Weight Loss Drug Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Medical Weight Loss Drug Production by Type (2021-2026) & (K Dose)
Table 49. World Medical Weight Loss Drug Production by Type (2027-2032) & (K Dose)
Table 50. World Medical Weight Loss Drug Production Value by Type (2021-2026) & (USD Million)
Table 51. World Medical Weight Loss Drug Production Value by Type (2027-2032) & (USD Million)
Table 52. World Medical Weight Loss Drug Average Price by Type (2021-2026) & (US$/Dose)
Table 53. World Medical Weight Loss Drug Average Price by Type (2027-2032) & (US$/Dose)
Table 54. World Medical Weight Loss Drug Production Value by Administration Route, (USD Million), 2021 & 2025 & 2032
Table 55. World Medical Weight Loss Drug Production by Administration Route (2021-2026) & (K Dose)
Table 56. World Medical Weight Loss Drug Production by Administration Route (2027-2032) & (K Dose)
Table 57. World Medical Weight Loss Drug Production Value by Administration Route (2021-2026) & (USD Million)
Table 58. World Medical Weight Loss Drug Production Value by Administration Route (2027-2032) & (USD Million)
Table 59. World Medical Weight Loss Drug Average Price by Administration Route (2021-2026) & (US$/Dose)
Table 60. World Medical Weight Loss Drug Average Price by Administration Route (2027-2032) & (US$/Dose)
Table 61. World Medical Weight Loss Drug Production Value by Dosage Form Strength, (USD Million), 2021 & 2025 & 2032
Table 62. World Medical Weight Loss Drug Production by Dosage Form Strength (2021-2026) & (K Dose)
Table 63. World Medical Weight Loss Drug Production by Dosage Form Strength (2027-2032) & (K Dose)
Table 64. World Medical Weight Loss Drug Production Value by Dosage Form Strength (2021-2026) & (USD Million)
Table 65. World Medical Weight Loss Drug Production Value by Dosage Form Strength (2027-2032) & (USD Million)
Table 66. World Medical Weight Loss Drug Average Price by Dosage Form Strength (2021-2026) & (US$/Dose)
Table 67. World Medical Weight Loss Drug Average Price by Dosage Form Strength (2027-2032) & (US$/Dose)
Table 68. World Medical Weight Loss Drug Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Medical Weight Loss Drug Production by Application (2021-2026) & (K Dose)
Table 70. World Medical Weight Loss Drug Production by Application (2027-2032) & (K Dose)
Table 71. World Medical Weight Loss Drug Production Value by Application (2021-2026) & (USD Million)
Table 72. World Medical Weight Loss Drug Production Value by Application (2027-2032) & (USD Million)
Table 73. World Medical Weight Loss Drug Average Price by Application (2021-2026) & (US$/Dose)
Table 74. World Medical Weight Loss Drug Average Price by Application (2027-2032) & (US$/Dose)
Table 75. Novo Nordisk A/S Basic Information, Manufacturing Base and Competitors
Table 76. Novo Nordisk A/S Major Business
Table 77. Novo Nordisk A/S Medical Weight Loss Drug Product and Services
Table 78. Novo Nordisk A/S Medical Weight Loss Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Novo Nordisk A/S Recent Developments/Updates
Table 80. Novo Nordisk A/S Competitive Strengths & Weaknesses
Table 81. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 82. Eli Lilly and Company Major Business
Table 83. Eli Lilly and Company Medical Weight Loss Drug Product and Services
Table 84. Eli Lilly and Company Medical Weight Loss Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Eli Lilly and Company Recent Developments/Updates
Table 86. Eli Lilly and Company Competitive Strengths & Weaknesses
Table 87. Amgen Inc. Basic Information, Manufacturing Base and Competitors
Table 88. Amgen Inc. Major Business
Table 89. Amgen Inc. Medical Weight Loss Drug Product and Services
Table 90. Amgen Inc. Medical Weight Loss Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Amgen Inc. Recent Developments/Updates
Table 92. Amgen Inc. Competitive Strengths & Weaknesses
Table 93. Altimmune, Inc. Basic Information, Manufacturing Base and Competitors
Table 94. Altimmune, Inc. Major Business
Table 95. Altimmune, Inc. Medical Weight Loss Drug Product and Services
Table 96. Altimmune, Inc. Medical Weight Loss Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Altimmune, Inc. Recent Developments/Updates
Table 98. Altimmune, Inc. Competitive Strengths & Weaknesses
Table 99. Viking Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table 100. Viking Therapeutics, Inc. Major Business
Table 101. Viking Therapeutics, Inc. Medical Weight Loss Drug Product and Services
Table 102. Viking Therapeutics, Inc. Medical Weight Loss Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Viking Therapeutics, Inc. Recent Developments/Updates
Table 104. Viking Therapeutics, Inc. Competitive Strengths & Weaknesses
Table 105. Structure Therapeutics Inc. Basic Information, Manufacturing Base and Competitors
Table 106. Structure Therapeutics Inc. Major Business
Table 107. Structure Therapeutics Inc. Medical Weight Loss Drug Product and Services
Table 108. Structure Therapeutics Inc. Medical Weight Loss Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Structure Therapeutics Inc. Recent Developments/Updates
Table 110. Structure Therapeutics Inc. Competitive Strengths & Weaknesses
Table 111. Boehringer Ingelheim International GmbH Basic Information, Manufacturing Base and Competitors
Table 112. Boehringer Ingelheim International GmbH Major Business
Table 113. Boehringer Ingelheim International GmbH Medical Weight Loss Drug Product and Services
Table 114. Boehringer Ingelheim International GmbH Medical Weight Loss Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Boehringer Ingelheim International GmbH Recent Developments/Updates
Table 116. Boehringer Ingelheim International GmbH Competitive Strengths & Weaknesses
Table 117. Rhythm Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 118. Rhythm Pharmaceuticals, Inc. Major Business
Table 119. Rhythm Pharmaceuticals, Inc. Medical Weight Loss Drug Product and Services
Table 120. Rhythm Pharmaceuticals, Inc. Medical Weight Loss Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Rhythm Pharmaceuticals, Inc. Recent Developments/Updates
Table 122. Rhythm Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
Table 123. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 124. Pfizer Inc. Major Business
Table 125. Pfizer Inc. Medical Weight Loss Drug Product and Services
Table 126. Pfizer Inc. Medical Weight Loss Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Pfizer Inc. Recent Developments/Updates
Table 128. Pfizer Inc. Competitive Strengths & Weaknesses
Table 129. Innovent Biologics, Inc. Basic Information, Manufacturing Base and Competitors
Table 130. Innovent Biologics, Inc. Major Business
Table 131. Innovent Biologics, Inc. Medical Weight Loss Drug Product and Services
Table 132. Innovent Biologics, Inc. Medical Weight Loss Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Innovent Biologics, Inc. Recent Developments/Updates
Table 134. Innovent Biologics, Inc. Competitive Strengths & Weaknesses
Table 135. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 136. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Major Business
Table 137. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Medical Weight Loss Drug Product and Services
Table 138. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Medical Weight Loss Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Developments/Updates
Table 140. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Competitive Strengths & Weaknesses
Table 141. Shanghai Junshi Biosciences Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 142. Shanghai Junshi Biosciences Co., Ltd. Major Business
Table 143. Shanghai Junshi Biosciences Co., Ltd. Medical Weight Loss Drug Product and Services
Table 144. Shanghai Junshi Biosciences Co., Ltd. Medical Weight Loss Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Shanghai Junshi Biosciences Co., Ltd. Recent Developments/Updates
Table 146. Shanghai Junshi Biosciences Co., Ltd. Competitive Strengths & Weaknesses
Table 147. Hangzhou Jiuyuan Gene Engineering Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 148. Hangzhou Jiuyuan Gene Engineering Co., Ltd. Major Business
Table 149. Hangzhou Jiuyuan Gene Engineering Co., Ltd. Medical Weight Loss Drug Product and Services
Table 150. Hangzhou Jiuyuan Gene Engineering Co., Ltd. Medical Weight Loss Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Hangzhou Jiuyuan Gene Engineering Co., Ltd. Recent Developments/Updates
Table 152. Hangzhou Jiuyuan Gene Engineering Co., Ltd. Competitive Strengths & Weaknesses
Table 153. Haisco Pharmaceutical Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 154. Haisco Pharmaceutical Group Co., Ltd. Major Business
Table 155. Haisco Pharmaceutical Group Co., Ltd. Medical Weight Loss Drug Product and Services
Table 156. Haisco Pharmaceutical Group Co., Ltd. Medical Weight Loss Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Haisco Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 158. Haisco Pharmaceutical Group Co., Ltd. Competitive Strengths & Weaknesses
Table 159. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 160. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Major Business
Table 161. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Medical Weight Loss Drug Product and Services
Table 162. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Medical Weight Loss Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 164. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 165. Tonghua Dongbao Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 166. Tonghua Dongbao Pharmaceutical Co., Ltd. Major Business
Table 167. Tonghua Dongbao Pharmaceutical Co., Ltd. Medical Weight Loss Drug Product and Services
Table 168. Tonghua Dongbao Pharmaceutical Co., Ltd. Medical Weight Loss Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Tonghua Dongbao Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 170. Tonghua Dongbao Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 171. Gan & Lee Pharmaceuticals Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 172. Gan & Lee Pharmaceuticals Co., Ltd. Major Business
Table 173. Gan & Lee Pharmaceuticals Co., Ltd. Medical Weight Loss Drug Product and Services
Table 174. Gan & Lee Pharmaceuticals Co., Ltd. Medical Weight Loss Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Gan & Lee Pharmaceuticals Co., Ltd. Recent Developments/Updates
Table 176. Gan & Lee Pharmaceuticals Co., Ltd. Competitive Strengths & Weaknesses
Table 177. Huadong Medicine Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 178. Huadong Medicine Co., Ltd. Major Business
Table 179. Huadong Medicine Co., Ltd. Medical Weight Loss Drug Product and Services
Table 180. Huadong Medicine Co., Ltd. Medical Weight Loss Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 181. Huadong Medicine Co., Ltd. Recent Developments/Updates
Table 182. Huadong Medicine Co., Ltd. Competitive Strengths & Weaknesses
Table 183. Livzon Pharmaceutical Group Inc. Basic Information, Manufacturing Base and Competitors
Table 184. Livzon Pharmaceutical Group Inc. Major Business
Table 185. Livzon Pharmaceutical Group Inc. Medical Weight Loss Drug Product and Services
Table 186. Livzon Pharmaceutical Group Inc. Medical Weight Loss Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 187. Livzon Pharmaceutical Group Inc. Recent Developments/Updates
Table 188. Livzon Pharmaceutical Group Inc. Competitive Strengths & Weaknesses
Table 189. CSPC Pharmaceutical Group Limited Basic Information, Manufacturing Base and Competitors
Table 190. CSPC Pharmaceutical Group Limited Major Business
Table 191. CSPC Pharmaceutical Group Limited Medical Weight Loss Drug Product and Services
Table 192. CSPC Pharmaceutical Group Limited Medical Weight Loss Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 193. CSPC Pharmaceutical Group Limited Recent Developments/Updates
Table 194. CSPC Pharmaceutical Group Limited Competitive Strengths & Weaknesses
Table 195. Global Key Players of Medical Weight Loss Drug Upstream (Raw Materials)
Table 196. Global Medical Weight Loss Drug Typical Customers
Table 197. Medical Weight Loss Drug Typical Distributors
Table 1. World Medical Weight Loss Drug Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Medical Weight Loss Drug Production Value by Region (2021-2026) & (USD Million)
Table 3. World Medical Weight Loss Drug Production Value by Region (2027-2032) & (USD Million)
Table 4. World Medical Weight Loss Drug Production Value Market Share by Region (2021-2026)
Table 5. World Medical Weight Loss Drug Production Value Market Share by Region (2027-2032)
Table 6. World Medical Weight Loss Drug Production by Region (2021-2026) & (K Dose)
Table 7. World Medical Weight Loss Drug Production by Region (2027-2032) & (K Dose)
Table 8. World Medical Weight Loss Drug Production Market Share by Region (2021-2026)
Table 9. World Medical Weight Loss Drug Production Market Share by Region (2027-2032)
Table 10. World Medical Weight Loss Drug Average Price by Region (2021-2026) & (US$/Dose)
Table 11. World Medical Weight Loss Drug Average Price by Region (2027-2032) & (US$/Dose)
Table 12. Medical Weight Loss Drug Major Market Trends
Table 13. World Medical Weight Loss Drug Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World Medical Weight Loss Drug Consumption by Region (2021-2026) & (K Dose)
Table 15. World Medical Weight Loss Drug Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World Medical Weight Loss Drug Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Medical Weight Loss Drug Producers in 2025
Table 18. World Medical Weight Loss Drug Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key Medical Weight Loss Drug Producers in 2025
Table 20. World Medical Weight Loss Drug Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 21. Global Medical Weight Loss Drug Company Evaluation Quadrant
Table 22. World Medical Weight Loss Drug Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Medical Weight Loss Drug Production Site of Key Manufacturer
Table 24. Medical Weight Loss Drug Market: Company Product Type Footprint
Table 25. Medical Weight Loss Drug Market: Company Product Application Footprint
Table 26. Medical Weight Loss Drug Competitive Factors
Table 27. Medical Weight Loss Drug New Entrant and Capacity Expansion Plans
Table 28. Medical Weight Loss Drug Mergers & Acquisitions Activity
Table 29. United States VS China Medical Weight Loss Drug Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Medical Weight Loss Drug Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China Medical Weight Loss Drug Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based Medical Weight Loss Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Medical Weight Loss Drug Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Medical Weight Loss Drug Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Medical Weight Loss Drug Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers Medical Weight Loss Drug Production Market Share (2021-2026)
Table 37. China Based Medical Weight Loss Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Medical Weight Loss Drug Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Medical Weight Loss Drug Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Medical Weight Loss Drug Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers Medical Weight Loss Drug Production Market Share (2021-2026)
Table 42. Rest of World Based Medical Weight Loss Drug Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Medical Weight Loss Drug Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Medical Weight Loss Drug Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Medical Weight Loss Drug Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers Medical Weight Loss Drug Production Market Share (2021-2026)
Table 47. World Medical Weight Loss Drug Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Medical Weight Loss Drug Production by Type (2021-2026) & (K Dose)
Table 49. World Medical Weight Loss Drug Production by Type (2027-2032) & (K Dose)
Table 50. World Medical Weight Loss Drug Production Value by Type (2021-2026) & (USD Million)
Table 51. World Medical Weight Loss Drug Production Value by Type (2027-2032) & (USD Million)
Table 52. World Medical Weight Loss Drug Average Price by Type (2021-2026) & (US$/Dose)
Table 53. World Medical Weight Loss Drug Average Price by Type (2027-2032) & (US$/Dose)
Table 54. World Medical Weight Loss Drug Production Value by Administration Route, (USD Million), 2021 & 2025 & 2032
Table 55. World Medical Weight Loss Drug Production by Administration Route (2021-2026) & (K Dose)
Table 56. World Medical Weight Loss Drug Production by Administration Route (2027-2032) & (K Dose)
Table 57. World Medical Weight Loss Drug Production Value by Administration Route (2021-2026) & (USD Million)
Table 58. World Medical Weight Loss Drug Production Value by Administration Route (2027-2032) & (USD Million)
Table 59. World Medical Weight Loss Drug Average Price by Administration Route (2021-2026) & (US$/Dose)
Table 60. World Medical Weight Loss Drug Average Price by Administration Route (2027-2032) & (US$/Dose)
Table 61. World Medical Weight Loss Drug Production Value by Dosage Form Strength, (USD Million), 2021 & 2025 & 2032
Table 62. World Medical Weight Loss Drug Production by Dosage Form Strength (2021-2026) & (K Dose)
Table 63. World Medical Weight Loss Drug Production by Dosage Form Strength (2027-2032) & (K Dose)
Table 64. World Medical Weight Loss Drug Production Value by Dosage Form Strength (2021-2026) & (USD Million)
Table 65. World Medical Weight Loss Drug Production Value by Dosage Form Strength (2027-2032) & (USD Million)
Table 66. World Medical Weight Loss Drug Average Price by Dosage Form Strength (2021-2026) & (US$/Dose)
Table 67. World Medical Weight Loss Drug Average Price by Dosage Form Strength (2027-2032) & (US$/Dose)
Table 68. World Medical Weight Loss Drug Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Medical Weight Loss Drug Production by Application (2021-2026) & (K Dose)
Table 70. World Medical Weight Loss Drug Production by Application (2027-2032) & (K Dose)
Table 71. World Medical Weight Loss Drug Production Value by Application (2021-2026) & (USD Million)
Table 72. World Medical Weight Loss Drug Production Value by Application (2027-2032) & (USD Million)
Table 73. World Medical Weight Loss Drug Average Price by Application (2021-2026) & (US$/Dose)
Table 74. World Medical Weight Loss Drug Average Price by Application (2027-2032) & (US$/Dose)
Table 75. Novo Nordisk A/S Basic Information, Manufacturing Base and Competitors
Table 76. Novo Nordisk A/S Major Business
Table 77. Novo Nordisk A/S Medical Weight Loss Drug Product and Services
Table 78. Novo Nordisk A/S Medical Weight Loss Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Novo Nordisk A/S Recent Developments/Updates
Table 80. Novo Nordisk A/S Competitive Strengths & Weaknesses
Table 81. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 82. Eli Lilly and Company Major Business
Table 83. Eli Lilly and Company Medical Weight Loss Drug Product and Services
Table 84. Eli Lilly and Company Medical Weight Loss Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Eli Lilly and Company Recent Developments/Updates
Table 86. Eli Lilly and Company Competitive Strengths & Weaknesses
Table 87. Amgen Inc. Basic Information, Manufacturing Base and Competitors
Table 88. Amgen Inc. Major Business
Table 89. Amgen Inc. Medical Weight Loss Drug Product and Services
Table 90. Amgen Inc. Medical Weight Loss Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Amgen Inc. Recent Developments/Updates
Table 92. Amgen Inc. Competitive Strengths & Weaknesses
Table 93. Altimmune, Inc. Basic Information, Manufacturing Base and Competitors
Table 94. Altimmune, Inc. Major Business
Table 95. Altimmune, Inc. Medical Weight Loss Drug Product and Services
Table 96. Altimmune, Inc. Medical Weight Loss Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Altimmune, Inc. Recent Developments/Updates
Table 98. Altimmune, Inc. Competitive Strengths & Weaknesses
Table 99. Viking Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table 100. Viking Therapeutics, Inc. Major Business
Table 101. Viking Therapeutics, Inc. Medical Weight Loss Drug Product and Services
Table 102. Viking Therapeutics, Inc. Medical Weight Loss Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Viking Therapeutics, Inc. Recent Developments/Updates
Table 104. Viking Therapeutics, Inc. Competitive Strengths & Weaknesses
Table 105. Structure Therapeutics Inc. Basic Information, Manufacturing Base and Competitors
Table 106. Structure Therapeutics Inc. Major Business
Table 107. Structure Therapeutics Inc. Medical Weight Loss Drug Product and Services
Table 108. Structure Therapeutics Inc. Medical Weight Loss Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Structure Therapeutics Inc. Recent Developments/Updates
Table 110. Structure Therapeutics Inc. Competitive Strengths & Weaknesses
Table 111. Boehringer Ingelheim International GmbH Basic Information, Manufacturing Base and Competitors
Table 112. Boehringer Ingelheim International GmbH Major Business
Table 113. Boehringer Ingelheim International GmbH Medical Weight Loss Drug Product and Services
Table 114. Boehringer Ingelheim International GmbH Medical Weight Loss Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Boehringer Ingelheim International GmbH Recent Developments/Updates
Table 116. Boehringer Ingelheim International GmbH Competitive Strengths & Weaknesses
Table 117. Rhythm Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 118. Rhythm Pharmaceuticals, Inc. Major Business
Table 119. Rhythm Pharmaceuticals, Inc. Medical Weight Loss Drug Product and Services
Table 120. Rhythm Pharmaceuticals, Inc. Medical Weight Loss Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Rhythm Pharmaceuticals, Inc. Recent Developments/Updates
Table 122. Rhythm Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
Table 123. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 124. Pfizer Inc. Major Business
Table 125. Pfizer Inc. Medical Weight Loss Drug Product and Services
Table 126. Pfizer Inc. Medical Weight Loss Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Pfizer Inc. Recent Developments/Updates
Table 128. Pfizer Inc. Competitive Strengths & Weaknesses
Table 129. Innovent Biologics, Inc. Basic Information, Manufacturing Base and Competitors
Table 130. Innovent Biologics, Inc. Major Business
Table 131. Innovent Biologics, Inc. Medical Weight Loss Drug Product and Services
Table 132. Innovent Biologics, Inc. Medical Weight Loss Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Innovent Biologics, Inc. Recent Developments/Updates
Table 134. Innovent Biologics, Inc. Competitive Strengths & Weaknesses
Table 135. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 136. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Major Business
Table 137. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Medical Weight Loss Drug Product and Services
Table 138. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Medical Weight Loss Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Developments/Updates
Table 140. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Competitive Strengths & Weaknesses
Table 141. Shanghai Junshi Biosciences Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 142. Shanghai Junshi Biosciences Co., Ltd. Major Business
Table 143. Shanghai Junshi Biosciences Co., Ltd. Medical Weight Loss Drug Product and Services
Table 144. Shanghai Junshi Biosciences Co., Ltd. Medical Weight Loss Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Shanghai Junshi Biosciences Co., Ltd. Recent Developments/Updates
Table 146. Shanghai Junshi Biosciences Co., Ltd. Competitive Strengths & Weaknesses
Table 147. Hangzhou Jiuyuan Gene Engineering Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 148. Hangzhou Jiuyuan Gene Engineering Co., Ltd. Major Business
Table 149. Hangzhou Jiuyuan Gene Engineering Co., Ltd. Medical Weight Loss Drug Product and Services
Table 150. Hangzhou Jiuyuan Gene Engineering Co., Ltd. Medical Weight Loss Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Hangzhou Jiuyuan Gene Engineering Co., Ltd. Recent Developments/Updates
Table 152. Hangzhou Jiuyuan Gene Engineering Co., Ltd. Competitive Strengths & Weaknesses
Table 153. Haisco Pharmaceutical Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 154. Haisco Pharmaceutical Group Co., Ltd. Major Business
Table 155. Haisco Pharmaceutical Group Co., Ltd. Medical Weight Loss Drug Product and Services
Table 156. Haisco Pharmaceutical Group Co., Ltd. Medical Weight Loss Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Haisco Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 158. Haisco Pharmaceutical Group Co., Ltd. Competitive Strengths & Weaknesses
Table 159. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 160. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Major Business
Table 161. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Medical Weight Loss Drug Product and Services
Table 162. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Medical Weight Loss Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 164. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 165. Tonghua Dongbao Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 166. Tonghua Dongbao Pharmaceutical Co., Ltd. Major Business
Table 167. Tonghua Dongbao Pharmaceutical Co., Ltd. Medical Weight Loss Drug Product and Services
Table 168. Tonghua Dongbao Pharmaceutical Co., Ltd. Medical Weight Loss Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Tonghua Dongbao Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 170. Tonghua Dongbao Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 171. Gan & Lee Pharmaceuticals Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 172. Gan & Lee Pharmaceuticals Co., Ltd. Major Business
Table 173. Gan & Lee Pharmaceuticals Co., Ltd. Medical Weight Loss Drug Product and Services
Table 174. Gan & Lee Pharmaceuticals Co., Ltd. Medical Weight Loss Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Gan & Lee Pharmaceuticals Co., Ltd. Recent Developments/Updates
Table 176. Gan & Lee Pharmaceuticals Co., Ltd. Competitive Strengths & Weaknesses
Table 177. Huadong Medicine Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 178. Huadong Medicine Co., Ltd. Major Business
Table 179. Huadong Medicine Co., Ltd. Medical Weight Loss Drug Product and Services
Table 180. Huadong Medicine Co., Ltd. Medical Weight Loss Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 181. Huadong Medicine Co., Ltd. Recent Developments/Updates
Table 182. Huadong Medicine Co., Ltd. Competitive Strengths & Weaknesses
Table 183. Livzon Pharmaceutical Group Inc. Basic Information, Manufacturing Base and Competitors
Table 184. Livzon Pharmaceutical Group Inc. Major Business
Table 185. Livzon Pharmaceutical Group Inc. Medical Weight Loss Drug Product and Services
Table 186. Livzon Pharmaceutical Group Inc. Medical Weight Loss Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 187. Livzon Pharmaceutical Group Inc. Recent Developments/Updates
Table 188. Livzon Pharmaceutical Group Inc. Competitive Strengths & Weaknesses
Table 189. CSPC Pharmaceutical Group Limited Basic Information, Manufacturing Base and Competitors
Table 190. CSPC Pharmaceutical Group Limited Major Business
Table 191. CSPC Pharmaceutical Group Limited Medical Weight Loss Drug Product and Services
Table 192. CSPC Pharmaceutical Group Limited Medical Weight Loss Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 193. CSPC Pharmaceutical Group Limited Recent Developments/Updates
Table 194. CSPC Pharmaceutical Group Limited Competitive Strengths & Weaknesses
Table 195. Global Key Players of Medical Weight Loss Drug Upstream (Raw Materials)
Table 196. Global Medical Weight Loss Drug Typical Customers
Table 197. Medical Weight Loss Drug Typical Distributors
LIST OF FIGURES
Figure 1. Medical Weight Loss Drug Picture
Figure 2. World Medical Weight Loss Drug Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Medical Weight Loss Drug Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Medical Weight Loss Drug Production (2021-2032) & (K Dose)
Figure 5. World Medical Weight Loss Drug Average Price (2021-2032) & (US$/Dose)
Figure 6. World Medical Weight Loss Drug Production Value Market Share by Region (2021-2032)
Figure 7. World Medical Weight Loss Drug Production Market Share by Region (2021-2032)
Figure 8. North America Medical Weight Loss Drug Production (2021-2032) & (K Dose)
Figure 9. Europe Medical Weight Loss Drug Production (2021-2032) & (K Dose)
Figure 10. China Medical Weight Loss Drug Production (2021-2032) & (K Dose)
Figure 11. Japan Medical Weight Loss Drug Production (2021-2032) & (K Dose)
Figure 12. India Medical Weight Loss Drug Production (2021-2032) & (K Dose)
Figure 13. Medical Weight Loss Drug Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Medical Weight Loss Drug Consumption (2021-2032) & (K Dose)
Figure 16. World Medical Weight Loss Drug Consumption Market Share by Region (2021-2032)
Figure 17. United States Medical Weight Loss Drug Consumption (2021-2032) & (K Dose)
Figure 18. China Medical Weight Loss Drug Consumption (2021-2032) & (K Dose)
Figure 19. Europe Medical Weight Loss Drug Consumption (2021-2032) & (K Dose)
Figure 20. Japan Medical Weight Loss Drug Consumption (2021-2032) & (K Dose)
Figure 21. South Korea Medical Weight Loss Drug Consumption (2021-2032) & (K Dose)
Figure 22. ASEAN Medical Weight Loss Drug Consumption (2021-2032) & (K Dose)
Figure 23. India Medical Weight Loss Drug Consumption (2021-2032) & (K Dose)
Figure 24. Producer Shipments of Medical Weight Loss Drug by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Medical Weight Loss Drug Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Medical Weight Loss Drug Markets in 2025
Figure 27. United States VS China: Medical Weight Loss Drug Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Medical Weight Loss Drug Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Medical Weight Loss Drug Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Medical Weight Loss Drug Production Market Share 2025
Figure 31. China Based Manufacturers Medical Weight Loss Drug Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Medical Weight Loss Drug Production Market Share 2025
Figure 33. World Medical Weight Loss Drug Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Medical Weight Loss Drug Production Value Market Share by Type in 2025
Figure 35. GLP-1 Receptor Agonist Drugs
Figure 36. Dual GIP/GLP-1 Receptor Agonist Drugs
Figure 37. Other Metabolic Pathway Drugs
Figure 38. World Medical Weight Loss Drug Production Market Share by Type (2021-2032)
Figure 39. World Medical Weight Loss Drug Production Value Market Share by Type (2021-2032)
Figure 40. World Medical Weight Loss Drug Average Price by Type (2021-2032) & (US$/Dose)
Figure 41. World Medical Weight Loss Drug Production Value by Administration Route, (USD Million), 2021 & 2025 & 2032
Figure 42. World Medical Weight Loss Drug Production Value Market Share by Administration Route in 2025
Figure 43. Injectable Weight Loss Drugs
Figure 44. Oral Weight Loss Drugs
Figure 45. Implantable Weight Loss Drugs
Figure 46. World Medical Weight Loss Drug Production Market Share by Administration Route (2021-2032)
Figure 47. World Medical Weight Loss Drug Production Value Market Share by Administration Route (2021-2032)
Figure 48. World Medical Weight Loss Drug Average Price by Administration Route (2021-2032) & (US$/Dose)
Figure 49. World Medical Weight Loss Drug Production Value by Dosage Form Strength, (USD Million), 2021 & 2025 & 2032
Figure 50. World Medical Weight Loss Drug Production Value Market Share by Dosage Form Strength in 2025
Figure 51. Low Dose Formulation (<5 mg per dose)
Figure 52. Medium Dose Formulation (5–10 mg per dose)
Figure 53. High Dose Formulation (>10 mg per dose)
Figure 54. World Medical Weight Loss Drug Production Market Share by Dosage Form Strength (2021-2032)
Figure 55. World Medical Weight Loss Drug Production Value Market Share by Dosage Form Strength (2021-2032)
Figure 56. World Medical Weight Loss Drug Average Price by Dosage Form Strength (2021-2032) & (US$/Dose)
Figure 57. World Medical Weight Loss Drug Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 58. World Medical Weight Loss Drug Production Value Market Share by Application in 2025
Figure 59. Obesity Treatment
Figure 60. Overweight Management
Figure 61. Weight-Related Metabolic Disease Treatment
Figure 62. Other
Figure 63. World Medical Weight Loss Drug Production Market Share by Application (2021-2032)
Figure 64. World Medical Weight Loss Drug Production Value Market Share by Application (2021-2032)
Figure 65. World Medical Weight Loss Drug Average Price by Application (2021-2032) & (US$/Dose)
Figure 66. Medical Weight Loss Drug Industry Chain
Figure 67. Medical Weight Loss Drug Procurement Model
Figure 68. Medical Weight Loss Drug Sales Model
Figure 69. Medical Weight Loss Drug Sales Channels, Direct Sales, and Distribution
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Medical Weight Loss Drug Picture
Figure 2. World Medical Weight Loss Drug Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Medical Weight Loss Drug Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Medical Weight Loss Drug Production (2021-2032) & (K Dose)
Figure 5. World Medical Weight Loss Drug Average Price (2021-2032) & (US$/Dose)
Figure 6. World Medical Weight Loss Drug Production Value Market Share by Region (2021-2032)
Figure 7. World Medical Weight Loss Drug Production Market Share by Region (2021-2032)
Figure 8. North America Medical Weight Loss Drug Production (2021-2032) & (K Dose)
Figure 9. Europe Medical Weight Loss Drug Production (2021-2032) & (K Dose)
Figure 10. China Medical Weight Loss Drug Production (2021-2032) & (K Dose)
Figure 11. Japan Medical Weight Loss Drug Production (2021-2032) & (K Dose)
Figure 12. India Medical Weight Loss Drug Production (2021-2032) & (K Dose)
Figure 13. Medical Weight Loss Drug Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Medical Weight Loss Drug Consumption (2021-2032) & (K Dose)
Figure 16. World Medical Weight Loss Drug Consumption Market Share by Region (2021-2032)
Figure 17. United States Medical Weight Loss Drug Consumption (2021-2032) & (K Dose)
Figure 18. China Medical Weight Loss Drug Consumption (2021-2032) & (K Dose)
Figure 19. Europe Medical Weight Loss Drug Consumption (2021-2032) & (K Dose)
Figure 20. Japan Medical Weight Loss Drug Consumption (2021-2032) & (K Dose)
Figure 21. South Korea Medical Weight Loss Drug Consumption (2021-2032) & (K Dose)
Figure 22. ASEAN Medical Weight Loss Drug Consumption (2021-2032) & (K Dose)
Figure 23. India Medical Weight Loss Drug Consumption (2021-2032) & (K Dose)
Figure 24. Producer Shipments of Medical Weight Loss Drug by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Medical Weight Loss Drug Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Medical Weight Loss Drug Markets in 2025
Figure 27. United States VS China: Medical Weight Loss Drug Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Medical Weight Loss Drug Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Medical Weight Loss Drug Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Medical Weight Loss Drug Production Market Share 2025
Figure 31. China Based Manufacturers Medical Weight Loss Drug Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Medical Weight Loss Drug Production Market Share 2025
Figure 33. World Medical Weight Loss Drug Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Medical Weight Loss Drug Production Value Market Share by Type in 2025
Figure 35. GLP-1 Receptor Agonist Drugs
Figure 36. Dual GIP/GLP-1 Receptor Agonist Drugs
Figure 37. Other Metabolic Pathway Drugs
Figure 38. World Medical Weight Loss Drug Production Market Share by Type (2021-2032)
Figure 39. World Medical Weight Loss Drug Production Value Market Share by Type (2021-2032)
Figure 40. World Medical Weight Loss Drug Average Price by Type (2021-2032) & (US$/Dose)
Figure 41. World Medical Weight Loss Drug Production Value by Administration Route, (USD Million), 2021 & 2025 & 2032
Figure 42. World Medical Weight Loss Drug Production Value Market Share by Administration Route in 2025
Figure 43. Injectable Weight Loss Drugs
Figure 44. Oral Weight Loss Drugs
Figure 45. Implantable Weight Loss Drugs
Figure 46. World Medical Weight Loss Drug Production Market Share by Administration Route (2021-2032)
Figure 47. World Medical Weight Loss Drug Production Value Market Share by Administration Route (2021-2032)
Figure 48. World Medical Weight Loss Drug Average Price by Administration Route (2021-2032) & (US$/Dose)
Figure 49. World Medical Weight Loss Drug Production Value by Dosage Form Strength, (USD Million), 2021 & 2025 & 2032
Figure 50. World Medical Weight Loss Drug Production Value Market Share by Dosage Form Strength in 2025
Figure 51. Low Dose Formulation (<5 mg per dose)
Figure 52. Medium Dose Formulation (5–10 mg per dose)
Figure 53. High Dose Formulation (>10 mg per dose)
Figure 54. World Medical Weight Loss Drug Production Market Share by Dosage Form Strength (2021-2032)
Figure 55. World Medical Weight Loss Drug Production Value Market Share by Dosage Form Strength (2021-2032)
Figure 56. World Medical Weight Loss Drug Average Price by Dosage Form Strength (2021-2032) & (US$/Dose)
Figure 57. World Medical Weight Loss Drug Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 58. World Medical Weight Loss Drug Production Value Market Share by Application in 2025
Figure 59. Obesity Treatment
Figure 60. Overweight Management
Figure 61. Weight-Related Metabolic Disease Treatment
Figure 62. Other
Figure 63. World Medical Weight Loss Drug Production Market Share by Application (2021-2032)
Figure 64. World Medical Weight Loss Drug Production Value Market Share by Application (2021-2032)
Figure 65. World Medical Weight Loss Drug Average Price by Application (2021-2032) & (US$/Dose)
Figure 66. Medical Weight Loss Drug Industry Chain
Figure 67. Medical Weight Loss Drug Procurement Model
Figure 68. Medical Weight Loss Drug Sales Model
Figure 69. Medical Weight Loss Drug Sales Channels, Direct Sales, and Distribution
Figure 70. Methodology
Figure 71. Research Process and Data Source
